Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic – JAMA Internal Medicine Author Interview: Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms – JAMA Internal Medicine Commentaries: Expert reaction to study looking at the association of self-reported […]
The post Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection. appeared first on Links Medicus.
Practice Review: COVID-19 rapid diagnostics.
COVID-19 rapid diagnostics: practice review – Emergency Medicine Journal
The post Practice Review: COVID-19 rapid diagnostics. appeared first on Links Medicus.
COVID-19 vaccination in pregnancy, pediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety.
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety – Drug Safety
The post COVID-19 vaccination in pregnancy, pediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety. appeared first on Links Medicus.
[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.
Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR Study Commentaries: Expert reaction to press release from Pfizer giving interim analysis of their Phase 2/3 EPIC-HR study of PAXLOVID™ in non-hospitalized high-risk adults with COVID-19 – Science Media Centre Pfizer’s Good News […]
The post [Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. appeared first on Links Medicus.
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first – NPR Related: Merck to allow other nations to produce new COVID-19 antiviral. Video: Merck’s Covid pill could transform treatment. Here’s how it works. How antiviral pill Molnupiravir shot ahead in the COVID drug hunt. What we know — and don’t know — […]
The post The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first. appeared first on Links Medicus.
Review: SARS-CoV-2 indoor air transmission is a threat that can be addressed with science.
SARS-CoV-2 indoor air transmission is a threat that can be addressed with science – Proceedings of the National Academies of Sciences Related: Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Editorial: Covid-19 has redefined airborne transmission Covid-19: What do we know about airborne transmission of SARS-CoV-2? Real-world data show that filters clean COVID-causing […]
The post Review: SARS-CoV-2 indoor air transmission is a threat that can be addressed with science. appeared first on Links Medicus.
Study compares the decline in effectiveness for Moderna, Pfizer, and Janssen vaccines and consequences for mortality.
Original study: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 – Science News release: Breakthrough Infection Study Compares Decline in Vaccine Effectiveness and Consequences for Mortality – Public Health Institute Commentary on Twitter A new study of more than 780,000 United States Veterans shows that, although vaccination remains protective against #SARSCoV2 infection, […]
The post Study compares the decline in effectiveness for Moderna, Pfizer, and Janssen vaccines and consequences for mortality. appeared first on Links Medicus.
M-A: Zinc might help to stave off respiratory infection symptoms and cut illness duration – “But quality of evidence variable, and no clarity on optimal formulation or dose”.
News Release: Zinc might help to stave off respiratory infection symptoms and cut illness duration – BMJ Original Study: Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials – BMJ Open Commentary on Twitter A zinc supplement might help […]
The post M-A: Zinc might help to stave off respiratory infection symptoms and cut illness duration – “But quality of evidence variable, and no clarity on optimal formulation or dose”. appeared first on Links Medicus.
The USPSTF draft statement recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.
Chronic Obstructive Pulmonary Disease: Screening – U.S. Preventive Services Task Force Commentary: USPSTF Still Advises Against COPD Screening for Asymptomatic Adults – HealthDay
The post The USPSTF draft statement recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults. appeared first on Links Medicus.
ASH Guideline issued a conditional recommendation against routine use of outpatient anticoagulant prophylaxis in patients with COVID-19 being discharged from the hospital.
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis – Blood Advances
The post ASH Guideline issued a conditional recommendation against routine use of outpatient anticoagulant prophylaxis in patients with COVID-19 being discharged from the hospital. appeared first on Links Medicus.